A detailed history of Fjarde Ap Fonden transactions in Baxter International Inc stock. As of the latest transaction made, Fjarde Ap Fonden holds 74,960 shares of BAX stock, worth $2.68 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
74,960
Previous 78,860 4.95%
Holding current value
$2.68 Million
Previous $3.05 Million 5.08%
% of portfolio
0.04%
Previous 0.04%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

SELL
$37.88 - $43.77 $147,732 - $170,703
-3,900 Reduced 4.95%
74,960 $3.2 Million
Q3 2023

Oct 23, 2023

SELL
$37.32 - $49.29 $317,220 - $418,965
-8,500 Reduced 9.73%
78,860 $2.98 Million
Q2 2023

Aug 02, 2023

BUY
$39.98 - $47.68 $1.52 Million - $1.81 Million
37,900 Added 76.63%
87,360 $3.98 Million
Q1 2023

May 15, 2023

SELL
$37.58 - $52.57 $496,056 - $693,924
-13,200 Reduced 21.07%
49,460 $2.01 Million
Q4 2022

Feb 14, 2023

SELL
$49.7 - $57.71 $2.63 Million - $3.05 Million
-52,919 Reduced 45.79%
62,660 $3.19 Million
Q2 2022

Aug 11, 2022

BUY
$63.83 - $80.0 $2.92 Million - $3.66 Million
45,700 Added 65.4%
115,579 $7.42 Million
Q1 2022

May 13, 2022

SELL
$76.85 - $89.45 $3.19 Million - $3.72 Million
-41,540 Reduced 37.28%
69,879 $5.42 Million
Q4 2021

Feb 15, 2022

SELL
$74.57 - $87.19 $1.13 Million - $1.32 Million
-15,144 Reduced 11.97%
111,419 $9.56 Million
Q3 2021

Nov 15, 2021

SELL
$73.77 - $83.61 $885,240 - $1 Million
-12,000 Reduced 8.66%
126,563 $10.2 Million
Q2 2021

Aug 12, 2021

SELL
$80.5 - $88.01 $652,050 - $712,881
-8,100 Reduced 5.52%
138,563 $11.2 Million
Q1 2021

May 17, 2021

SELL
$76.38 - $86.03 $175,674 - $197,869
-2,300 Reduced 1.54%
146,663 $12.4 Million
Q4 2020

Feb 12, 2021

BUY
$75.39 - $82.36 $4.33 Million - $4.73 Million
57,400 Added 62.69%
148,963 $12 Million
Q3 2020

Nov 13, 2020

BUY
$78.33 - $90.73 $454,314 - $526,234
5,800 Added 6.76%
91,563 $7.36 Million
Q2 2020

Aug 13, 2020

BUY
$78.66 - $94.14 $983,250 - $1.18 Million
12,500 Added 17.06%
85,763 $7.38 Million
Q1 2020

May 11, 2020

SELL
$71.57 - $93.3 $780,112 - $1.02 Million
-10,900 Reduced 12.95%
73,263 $5.95 Million
Q4 2019

Feb 10, 2020

SELL
$76.7 - $88.45 $5.18 Million - $5.97 Million
-67,498 Reduced 44.51%
84,163 $7.04 Million
Q3 2019

Oct 31, 2019

BUY
$81.4 - $89.78 $367,683 - $405,536
4,517 Added 3.07%
151,661 $13.3 Million
Q2 2019

Jul 17, 2019

SELL
$73.44 - $82.41 $359,856 - $403,809
-4,900 Reduced 3.22%
147,144 $12.1 Million
Q1 2019

Apr 29, 2019

BUY
$64.48 - $81.31 $2.5 Million - $3.15 Million
38,706 Added 34.15%
152,044 $12.4 Million
Q4 2018

Jan 31, 2019

SELL
$61.45 - $77.8 $1.62 Million - $2.05 Million
-26,300 Reduced 18.83%
113,338 $7.46 Million
Q3 2018

Nov 09, 2018

SELL
$70.71 - $77.75 $418,461 - $460,124
-5,918 Reduced 4.07%
139,638 $10.8 Million
Q2 2018

Jul 12, 2018

BUY
$63.43 - $75.41 $596,115 - $708,703
9,398 Added 6.9%
145,556 $10.7 Million
Q1 2018

May 07, 2018

BUY
$62.56 - $72.26 $61,934 - $71,537
990 Added 0.73%
136,158 $8.86 Million
Q4 2017

Feb 12, 2018

BUY
$61.45 - $66.05 $1.06 Million - $1.14 Million
17,328 Added 14.7%
135,168 $8.74 Million
Q3 2017

Nov 07, 2017

BUY
$59.5 - $64.61 $201,526 - $218,834
3,387 Added 2.96%
117,840 $7.39 Million
Q2 2017

Aug 08, 2017

BUY
N/A
114,453
114,453 $6.93 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $18B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Fjarde Ap Fonden Portfolio

Follow Fjarde Ap Fonden and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden , based on Form 13F filings with the SEC.

News

Stay updated on Fjarde Ap Fonden with notifications on news.